Sign In
Buy BDX
$145.61
+1.18 (+0.82%)
At Close: Jun 03, 2026
Here's Why Becton Dickinson (BDX) is a Strong Value Stock
10:41am, Wednesday, 27'th Aug 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Best Dividend Kings: August 2025
10:13pm, Sunday, 24'th Aug 2025
Dividend Kings underperformed SPY year-to-date but are showing stronger gains in August, with several stocks achieving double-digit returns in 2025. Fifteen Dividend Kings currently appear undervalued
Becton, Dickinson: Great Time To Buy This Dividend Aristocrat
08:00am, Monday, 18'th Aug 2025
BDX is now attractively valued with a forward PE of 13.7, well below its historical average, making it a compelling value stock. Strong growth in Pharmaceutical Systems and Interventional segments, ma
11 Dividend Aristocrats With Excellent Upside Potential In The Next Year
07:00am, Saturday, 16'th Aug 2025
Dividend Growth Outperformance: For over 50 years, dividend growers have delivered market-beating returns with lower volatility. The BTI Example: British American Tobacco went from six years of stagna
BD to Present at Wells Fargo 2025 Healthcare Conference
04:15pm, Thursday, 14'th Aug 2025
FRANKLIN LAKES, N.J. , Aug. 14, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Far
Here's Why Becton Dickinson (BDX) is a Strong Growth Stock
10:46am, Tuesday, 12'th Aug 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Heartland's 3 Tactical Q2 Moves: Trimming Risk, Harvesting Losses, And Raising Cash
11:05am, Monday, 11'th Aug 2025
We remain patient and opportunistic, raising cash to capitalize on future volatility and focusing on stocks meeting our 10 Principles of Value Investing™. We initiated a position in Applied Material
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term
10:41am, Monday, 11'th Aug 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
4 Overlooked Dividend Aristocrat Stocks with Up To 60%+ Growth Potential
07:07am, Sunday, 10'th Aug 2025
Dividend Aristocrat stocks are a select group of 69 stocks that have an unbroken track record of at least 25 consecutive years of dividend increases.
BD Stock Gains in Pre-Market Following Q3 Earnings Beat, Margins Up
12:06pm, Thursday, 07'th Aug 2025
BDX tops third-quarter fiscal 2025 earnings and margin estimates, with strong results from its Medical and Interventional segments.
Becton Dickinson Q3 Beats Estimates On Medical Device Boom
11:40am, Thursday, 07'th Aug 2025
As the healthcare industry continues to rebound from global disruptions, companies like Becton, Dickinson, and Company BDX are reporting robust financial performances that highlight their resilience
Here's What Key Metrics Tell Us About Becton Dickinson (BDX) Q3 Earnings
10:31am, Thursday, 07'th Aug 2025
Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall
Becton, Dickinson and Company (BDX) Q3 2025 Earnings Call Transcript
09:51am, Thursday, 07'th Aug 2025
Becton, Dickinson and Company (NYSE:BDX ) Q3 2025 Earnings Call August 7, 2025 8:00 AM ET Company Participants Christopher J. DelOrefice - Executive VP & CFO Greg Rodetis - Senior VP, Treasurer & Head
Becton Dickinson (BDX) Surpasses Q3 Earnings and Revenue Estimates
08:40am, Thursday, 07'th Aug 2025
Becton Dickinson (BDX) came out with quarterly earnings of $3.68 per share, beating the Zacks Consensus Estimate of $3.42 per share. This compares to earnings of $3.5 per share a year ago.
Becton Dickinson joins peer in raising annual profit forecast after results beat
07:34am, Thursday, 07'th Aug 2025
Becton Dickinson raised its forecast for annual profit on Thursday, after beating Wall Street estimates for third-quarter profit and sales on strong demand for its drug-delivery devices.
